Statistics for Enzo Biochem (id:10148 ENZ)

Valuation metrics

Market cap

54.33M

Enterprise value

5.47M

Trailing P/E (ttm)

Forward P/E

-2.67

PEG ratio

-2.67

Price/Sales (ttm)

1.70

Price/Book (mrq)

0.97

Enterprise Value/Revenue

0.17

Enterprise Value/EBITDA

-0.49

Overview

Shares outstanding

52.24M

Float

35.04M

Shares short

477.48K

% Held by insiders

0.24%

% Held by institutions

0.32%

Average volume (10 days)

169.93K

Average volume (90 days)

Price summary

52-Week low

0.97

52-Week high

1.50

52-Week change

-26.73%

Beta

0.73

50-Day moving average

1.13

200-Day moving average

1.16

Dividends and splits

Forward annual dividend rate

0.40

Forward annual dividend yield

0.40

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

December 02th, 2024

Ex-dividend date

November 15th, 2024

Last split factor

2:1

Last split date

October 21th, 2004

Financials

Fiscal year

Fiscal year ends

July 31th, 2024

Most recent quarter (mrq)

July 31th, 2024

Profitability

Profit margin

-81.73%

Operating margin

-38.75%

Operational effectiveness

Return on assets

-7.44%

Return on equity

-14.59%

Income statement

Revenue (ttm)

0.63

Revenue per share (ttm)

0.63

Quarterly revenue growth (yoy)

Gross profit (ttm)

14.63M

EBITDA

-11,093,000.00

Net income to common (ttm)

-9,817,000.00

Diluted EPS (ttm)

-0.19

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

52.37M

Total cash per share (mrq)

1.00

Total debt (mrq)

3.51M

Total Debt/Equity (mrq)

6.25

Current ratio (mrq)

282.50%

Book value per share (mrq)

1.07

Cash flow

Cash flow statement

-26,259,000.00

Levered free cash flow (LFCF)

-18,948,250.00